455 related articles for article (PubMed ID: 28038961)
1. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
[TBL] [Abstract][Full Text] [Related]
2. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of four once-daily aminoglycoside dosing nomograms.
Wallace AW; Jones M; Bertino JS
Pharmacotherapy; 2002 Sep; 22(9):1077-83. PubMed ID: 12222541
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
Kirkpatrick CM; Duffull SB; Begg EJ
Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
[TBL] [Abstract][Full Text] [Related]
7. Rationality of administered gentamicin dose in cerebral coma patients treated in an intensive care unit.
Janušonis T; Mačiulaitis R; Sveikata A; Milašius A; Kregždytė R
Medicina (Kaunas); 2011; 47(2):79-84. PubMed ID: 21734439
[TBL] [Abstract][Full Text] [Related]
8. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Drug Monitoring of Gentamicin Peak Concentrations in Critically Ill Patients.
Hodiamont CJ; Janssen JM; de Jong MD; Mathôt RA; Juffermans NP; van Hest RM
Ther Drug Monit; 2017 Oct; 39(5):522-530. PubMed ID: 28682925
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin.
Plajer SM; Chin PK; Vella-Brincat JW; Buffery PJ; Begg EJ
Ther Drug Monit; 2015 Feb; 37(1):98-103. PubMed ID: 24943063
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose.
Gonçalves-Pereira J; Martins A; Póvoa P
Clin Microbiol Infect; 2010 Aug; 16(8):1258-63. PubMed ID: 19832713
[TBL] [Abstract][Full Text] [Related]
13. Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis.
Roger C; Nucci B; Louart B; Friggeri A; Knani H; Evrard A; Lavigne JP; Allaouchiche B; Lefrant JY; Roberts JA; Muller L
J Antimicrob Chemother; 2016 Jan; 71(1):208-12. PubMed ID: 26429564
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin dosing in critically ill patients.
Hansen M; Christrup LL; Jarløv JO; Kampmann JP; Bonde J
Acta Anaesthesiol Scand; 2001 Jul; 45(6):734-40. PubMed ID: 11421832
[TBL] [Abstract][Full Text] [Related]
15. Single-dose gentamicin clearance is a predictor of creatinine clearance in spinal man.
Segal JL; Gilman TA; Thompson JF
Am J Ther; 2010; 17(4):390-5. PubMed ID: 19531933
[TBL] [Abstract][Full Text] [Related]
16. Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
Roger C; Nucci B; Molinari N; Bastide S; Saissi G; Pradel G; Barbar S; Aubert C; Lloret S; Elotmani L; Polge A; Lefrant JY; Roberts JA; Muller L
Int J Antimicrob Agents; 2015 Jul; 46(1):21-7. PubMed ID: 25857948
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
Xuan D; Nicolau DP; Nightingale CH
Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
19. Clinical audit of gentamicin use by Bayesian pharmacokinetic approach in critically ill children.
Sridharan K; Al Daylami A
J Infect Chemother; 2020 Jun; 26(6):540-548. PubMed ID: 32070645
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
Staatz CE; Byrne C; Thomson AH
Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
